|
| Home - Emicizumab (B02BX06) |
| |
| B02BX06 - Emicizumab | ATC-DDD Version 2016. Source: WHO | | B - Blood and Blood Forming Organs | | |
| | | B02B - Vitamin K and Other Hemostatics | | | The DDDs are based on treatment of hemorrhage associated with different deficiency states (e.g. vitamin K deficiency, deficiency of different blood coagulation factors etc.).
|
| | B02BX - Other Systemic Hemostatics | This group comprises systemic hemostatics, which cannot be classified elsewhere.
| The DDD for avatrombopag is based on the starting dose in the treatment of chronic immune thrombocytopenia.
|
| | B02BX06 - Emicizumab | | Dose | Route of administration | Note |
|---|
| | P | |
|
|
|
|
|
